openai.com·Apr 16, 2026
OpenAI has launched GPT-Rosalind, an advanced reasoning model designed to enhance drug discovery, genomics analysis, protein reasoning, and overall scientific research processes.
For a professional tracking advancements in AI, GPT-Rosalind represents a significant leap in applying large language models to specialized scientific domains, such as drug discovery and genomics. This development signals the potential for AI to revolutionize complex research workflows, suggesting an opportunity to explore partnerships or investments in AI-driven scientific research tools.